| |
|
|
|
|
|
|
|||
|
Blood, 20 August 2009, Vol. 114, No. 8, pp. 1576-1584. Prepublished online as a Blood First Edition Paper on June 8, 2009; DOI 10.1182/blood-2009-03-212704.
LYMPHOID NEOPLASIA Genetic fingerprinting of the development and progression of T-cell lymphoma in a murine model of atypical myeloproliferative disorder initiated by the ZNF198–fibroblast growth factor receptor-1 chimeric tyrosine kinase1 Medical College of Georgia Cancer Center, Augusta; and 2 Department of Cancer Genetics, Roswell Park Cancer Institute, Buffalo, NY
A mouse model of human ZNF198–fibroblast growth factor receptor-1 (FGFR1) stem cell leukemia lymphoma has been developed to investigate mechanisms of oncogenesis and progression. Using array-based comparative genomic hybridization, we followed disease progression after serial transplantation of ZNF198-FGFR1–transformed stem cells that give rise to a distinct myeloproliferative disorder and T-lymphoblastic leukemia. A consistent, frequently homozygous, chr14:53880459-55011545 deletion, containing the T-cell receptor
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||